Published in Biotech Business Week, March 8th, 2004
In August 2003, CRL entered into a contract research agreement with Merck KGaA to provide CRL's discovery research capabilities to Merck. During the recent collaboration project, CRL scientists synthesized multiple series of focused libraries under application of CRL's high-throughput medicinal chemistry platform to complement Merck's in-house lead finding efforts. Further details and financial terms were not disclosed.
"CRL helped us to acquire innovative molecules for our corporate screening collection," said...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.